• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - CORK CONTOUR PVA MICROSPHERES; AGENTS, EMBOLIC, FOR TREATMENT OF UTERINE FIBROIDS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - CORK CONTOUR PVA MICROSPHERES; AGENTS, EMBOLIC, FOR TREATMENT OF UTERINE FIBROIDS Back to Search Results
Model Number UNK90
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Blood Loss (2597)
Event Type  Injury  
Event Description
Same journal article as mdr id: 2134265-2014-04845, 2134265-2014-04847, 2134265-2014-04848, 2134265-2014-04849, 2134265-2014-04850 and 2134265-2014-04846.Reported via journal article.It was reported that post a transcatheter arterial embolization procedure, hysterectomy was performed.After the patient had a normal spontaneous vaginal delivery (nsvd), unilateral femoral artery catheterization was performed and pelvic angiography revealed hyperaemia.The patient received contour polyvinyl alcohol particles in both uterine arteries.An unspecified amount of time later, a hysterectomy was performed.
 
Manufacturer Narrative
Hwang, s.M., jeon, g.S., kim, s.H., lee, j.T., kim, m.D., choi, m.J.(2013).Transcatheter arterial embolization for the management of obstetric haemorrhage associated with placental abnormality in 40 cases.European society of radiology, 23:766-773.Device evaluated by manufacturer: it is indicated that the device will not be returned for evaluation; therefore a failure analysis of the complaint device could not be completed.A review of the batch history, historical trending, and similar complaint trending review for the product family will be conducted.If there is any further relevant information from that review, a supplemental medwatch will be filed.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CONTOUR PVA MICROSPHERES
Type of Device
AGENTS, EMBOLIC, FOR TREATMENT OF UTERINE FIBROIDS
Manufacturer (Section D)
BOSTON SCIENTIFIC - CORK
business and technology park
model farm road
cork
EI 
Manufacturer (Section G)
BOSTON SCIENTIFIC - CORK
business and technology park
model farm road
cork
EI  
Manufacturer Contact
ingrid matte
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key4024748
MDR Text Key4806543
Report Number2134265-2014-04844
Device Sequence Number1
Product Code NAJ
Combination Product (y/n)N
Reporter Country CodeKR
PMA/PMN Number
K030966
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 07/23/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/20/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberUNK90
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/23/2014
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age31 YR
-
-